摘要
慢性阻塞性肺疾病是一种慢性呼吸道炎症疾病,一旦合并肺动脉高压,将进一步缩短患者生存期。慢性阻塞性肺疾病相关的生物标志物可以为其合并肺动脉高压的诊断、治疗和预后评估作出贡献。本综述探讨中性粒细胞/淋巴细胞比率和血小板/淋巴细胞比值在慢性阻塞性肺疾病合并肺动脉高压的诊断、治疗及评价预后中的价值。
Chronic obstructive pulmonary disease(COPD)is a disease associated with chronic respiratory tract inflammation.Once complicated with pulmonary hypertension(PH),survival period of patients will be further shortened.The corresponding biomarkers can make a contribution for the diagnosis,treatment and prognosis assessment of COPD complicated PH.The present review explores value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in diagnosis,treatment and prognosis assessment of COPD complicated PH.
作者
王雪
陈宏
WANG Xue;CHEN Hong(Department of Respiratory Medicine,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)
出处
《心血管康复医学杂志》
CAS
2022年第6期754-757,共4页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
肺疾病
慢性阻塞性
高血压
肺性
诊断
Pulmonary disease,chronic obstructive
Hypertension,pulmonary
Diagnosis
